Upon the US approval of Cryotech‘s second patent (three more are still under review), we would like to share an update. Read the patent application!
CryoTech, a fully owned subsidiary of Gevasol, has accomplished a significant milestone in developing disruptive cryocooler technology, aiming at the low-SWaP market at a low-cost point.
Its one-of-a-kind, fully patented cryocooler has passed environmental tests in a temperature chamber, thus proving its full performance in terms of the requirements of significant detector system houses with whom we are in touch.
Based on this high confidence in the product, CryoTech plans to finalize complete performance tests at its laboratories and the site of a major customer.
Concurrently, it plans to build its manufacturing facility, enabling mass production at a very low cost compared to the existing compatible cryocoolers that target the low-SWaP market.
While proceeding with the production line, we invite interested parties to contact us.